Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure.

Bohlken MM, Brouwer RM, Mandl RC, Kahn RS, Hulshoff Pol HE.

Schizophr Bull. 2016 Sep;42(5):1167-75. doi: 10.1093/schbul/sbw034. Epub 2016 Apr 7.

2.

Both Financial and Cognitive Decline Predict Clinical Progression in MCI.

Gerstenecker A, Triebel KL, Martin R, Snyder S, Marson DC.

Alzheimer Dis Assoc Disord. 2016 Jan-Mar;30(1):27-34. doi: 10.1097/WAD.0000000000000120.

3.

Designing websites for persons with cognitive deficits: Design and usability of a psychoeducational intervention for persons with severe mental illness.

Rotondi AJ, Sinkule J, Haas GL, Spring MB, Litschge CM, Newhill CE, Ganguli R, Anderson CM.

Psychol Serv. 2007 Aug;4(3):202-224.

4.

Brain Structure in Neuropsychologically Defined Subgroups of Schizophrenia and Psychotic Bipolar Disorder.

Woodward ND, Heckers S.

Schizophr Bull. 2015 Nov;41(6):1349-59. doi: 10.1093/schbul/sbv048. Epub 2015 Apr 22.

5.

Memory deficits in schizophrenia: a selective review of functional magnetic resonance imaging (FMRI) studies.

Kraguljac NV, Srivastava A, Lahti AC.

Behav Sci (Basel). 2013 Jun 27;3(3):330-47. doi: 10.3390/bs3030330. eCollection 2013 Sep. Review.

6.

Discrimination within Recognition Memory in Schizophrenia.

McGuire KA, Blahnik MM, Sponheim SR.

Behav Sci (Basel). 2013 Jun 7;3(2):273-97. doi: 10.3390/bs3020273. eCollection 2013 Jun.

7.

Neuropsychological deficits in major depression reflect genetic/familial risk more than clinical history: a monozygotic discordant twin-pair study.

Hsu KJ, Young-Wolff KC, Kendler KS, Halberstadt LJ, Prescott CA.

Psychiatry Res. 2014 Jan 30;215(1):87-94. doi: 10.1016/j.psychres.2013.10.037. Epub 2013 Nov 5.

8.

Performance on the Wisconsin Card Sorting Test in families of schizophrenia patients with different familial loadings.

Lin SH, Liu CM, Hwang TJ, Hsieh MH, Hsiao PC, Faraone SV, Tsuang MT, Hwu HG, Chen WJ.

Schizophr Bull. 2013 May;39(3):537-46. doi: 10.1093/schbul/sbs141. Epub 2012 Nov 29.

9.

Brain activation patterns during visual episodic memory processing among first-degree relatives of schizophrenia subjects.

Stolz E, Pancholi KM, Goradia DD, Paul S, Keshavan MS, Nimgaonkar VL, Prasad KM.

Neuroimage. 2012 Nov 15;63(3):1154-61. doi: 10.1016/j.neuroimage.2012.08.030. Epub 2012 Aug 21.

10.

Common variants in MAGI2 gene are associated with increased risk for cognitive impairment in schizophrenic patients.

Koide T, Banno M, Aleksic B, Yamashita S, Kikuchi T, Kohmura K, Adachi Y, Kawano N, Kushima I, Nakamura Y, Okada T, Ikeda M, Ohi K, Yasuda Y, Hashimoto R, Inada T, Ujike H, Iidaka T, Suzuki M, Takeda M, Iwata N, Ozaki N.

PLoS One. 2012;7(5):e36836. doi: 10.1371/journal.pone.0036836. Epub 2012 May 23. Erratum in: PLoS One. 2012;7(9). doi:10.1371/annotation/47ca9c23-9fdd-47f6-9d36-db0a31769f22.

11.

The biology of schizophrenia.

Tamminga CA, Medoff DR.

Dialogues Clin Neurosci. 2000 Dec;2(4):339-48.

12.

Performance-based measures of everyday function in mild cognitive impairment.

Goldberg TE, Koppel J, Keehlisen L, Christen E, Dreses-Werringloer U, Conejero-Goldberg C, Gordon ML, Davies P.

Am J Psychiatry. 2010 Jul;167(7):845-53. doi: 10.1176/appi.ajp.2010.09050692. Epub 2010 Apr 1.

13.

Comorbid mood, psychosis, and marijuana abuse disorders: a theoretical review.

Wilson N, Cadet JL.

J Addict Dis. 2009 Oct;28(4):309-19. doi: 10.1080/10550880903182960. Review.

14.

Markers of vulnerability in schizophrenia.

Ladea M, Prelipceanu D.

J Med Life. 2009 Apr-Jun;2(2):155-64. Review.

15.

Pharmacology of epigenetics in brain disorders.

Narayan P, Dragunow M.

Br J Pharmacol. 2010 Jan 1;159(2):285-303. doi: 10.1111/j.1476-5381.2009.00526.x. Epub 2009 Dec 15. Review.

16.

What do we know about neuropsychological aspects of schizophrenia?

Palmer BW, Dawes SE, Heaton RK.

Neuropsychol Rev. 2009 Sep;19(3):365-84. doi: 10.1007/s11065-009-9109-y. Epub 2009 Jul 30. Review.

17.

The role of general intelligence as an intermediate phenotype for neuropsychiatric disorders.

Burdick KE, Gunawardane N, Woodberry K, Malhotra AK.

Cogn Neuropsychiatry. 2009;14(4-5):299-311. doi: 10.1080/13546800902805347. Review.

18.

Dopamine and psychosis: theory, pathomechanisms and intermediate phenotypes.

Tost H, Alam T, Meyer-Lindenberg A.

Neurosci Biobehav Rev. 2010 Apr;34(5):689-700. doi: 10.1016/j.neubiorev.2009.06.005. Epub 2009 Jun 24. Review.

19.

Familial aggregation of clinical and neurocognitive features in sibling pairs with and without schizophrenia.

Chen LS, Rice TK, Thompson PA, Barch DM, Csernansky JG.

Schizophr Res. 2009 Jun;111(1-3):159-66. doi: 10.1016/j.schres.2009.03.030. Epub 2009 Apr 23.

20.

Heritability of neurocognitive traits in familial schizophrenia.

Husted JA, Lim S, Chow EW, Greenwood C, Bassett AS.

Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 5;150B(6):845-53. doi: 10.1002/ajmg.b.30907.

Supplemental Content

Support Center